Enhancing the QUAlity and Transparency Of health Research
Reporting guidelines under development for observational studies or STROBE extensions
(year of development in brackets)
CARE for Acupuncture (2018)
STROBE checklist for conference abstracts
The STROBE Group have recently developed a checklist for conference abstracts.
Guideline for Reporting Environmental Epidemiology aNalyses (GREEN) (registered 20 December 2016)
This guideline will encompass studies that report on association between environmental exposures and health outcomes.
Standardized Protocol Items: Recommendations for Observational Studies (SPIROS) (registered 7 February 2017)
The guidelines aim to define comprehensive set of standard protocol items for observational studies, and by doing so facilitates and encourages researchers to prepare a study protocol of sufficient quality, prior to data collection.
Framework for Enhanced Reporting of Interrupted Time Series (FERITS) (registered 22 May 2018)
Reporting guidelines for interrupted time series studies. These are generally applied for the evaluation of public health interventions.
Outcome-based and observational metrics in surgical studies conducted in Lower-Middle Income Countries (LMICs).
This guideline is being developed by researchers at the Centre for Health Services Studies, University of Kent to improve the quality and completeness of reporting for Social Prescribing programmes. Social prescribing provides a non-medical referral option to improve health and wellbeing. Referrals can be to a range of programmes from befriending schemes, volunteering opportunities, supported education, arts, physical activity, as well as support with employment or legal advice.
Different Social Prescribing models have evolved across England reflecting local needs, service provider expertise and commissioning contracts. Consequently models vary greatly in terms of aims of the service, delivery partners, referral pathways, staffing, and service user outcomes making it difficult to identify features of a successful model, for whom social prescribing benefits, and under what circumstances.
SPoRTIER will provide a standardised useable template to capture contextual details on different programmes and how these programmes are being implemented to aid understanding of how social prescribing contributes to changes in health and wellbeing.
Development of SPoRTIER is based on the EQUATOR Network methodological framework for developing reporting guidelines.
There has been an exponential increase in studies applying metagenomic diagnostics, such as 16S PCR and deep-sequencing. The aim of this extension is to adapt the STROBE statement to be more applicable to these types of diagnostics, and to ensure transparency in publications on the same.
There will be a broad focus on metagenomics, and appendices on 1) Neurological infections, 2) Antimicrobial Resistance and 3) the Gut Microbiome.
PARAMEDICS-CARE is a consensus-based guideline under development for publishing pre-hospital case reports. It will be an extension to the CAse REport (CARE) clinical case reporting guideline.
Currently, case reports published on pre-hospital care rarely follow the CARE guideline. The quality of these publications is highly variable. The aim of the PARAMEDICS-CARE guideline is to improve the quality of pre-hospital care case reports.
Case reports are still an important source to provide evidence on acupuncture to clinicians and researchers. They can better present the real situation of clinical practice, reflect the individualized treatment characteristics of acupuncture treatment, and inherit the experience of prominent traditional medicine doctors.
CARE is a reporting guideline for case reports. The aim of the CARE for Acupuncture project is to develop an extension of CARE focused on acupuncture areas, which can enhance the transparency and quality of case reports on acupuncture.
The study design will refer to the methodology recommended by the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network, modified as appropriate. A literature review will be conducted, and an international multidisciplinary team is established, including a Development Group, a Delphi Panellists Group and an Advisory Group. From 1st October, 2018, the group started literatures and draft the item checklists. Three rounds of modified Delphi surveys, face-to-face consensus meetings, consultations with advisors, pilot tests of the draft list of reports and promotion of the checklist are under development. The group plans to update the reporting guideline regularly. The group intends to publish the reporting guideline on 2019, as an open access document.
Page last updated on: 20 of November 2018
|Clinical practice guidelines||AGREE||RIGHT|
|Animal pre-clinical studies||ARRIVE|
|Quality improvement studies||SQUIRE|